Name: UMIN ID:
Unique ID issued by UMIN | UMIN000015094 |
---|---|
Receipt number | R000017561 |
Scientific Title | PhaseII safety and efficacy study of alectinib in poor performance status patients with ALK positive, advanced NSCLC |
Date of disclosure of the study information | 2014/09/09 |
Last modified on | 2021/03/15 09:04:35 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2014/09/09 09:27:16 | ||
2 | Update | 2014/09/09 09:59:05 | Institute |
|
3 | Update | 2016/03/09 10:41:11 | Recruitment status |
|
4 | Update | 2016/09/09 09:53:05 | Name of primary person or sponsor Organization |
|
5 | Update | 2016/09/09 09:53:44 | Publication of results |
|
6 | Update | 2021/03/15 09:04:35 | Recruitment status Date of IRB |